<DOC>
	<DOC>NCT00420563</DOC>
	<brief_summary>The scope of the trial is to assess the free progression rate at 2 months for each group of patients.</brief_summary>
	<brief_title>Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative Cancer</brief_title>
	<detailed_description />
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Megestrol</mesh_term>
	<mesh_term>Megestrol Acetate</mesh_term>
	<criteria>Age &gt; or = 18 PSWHO &lt; or = 1 Histologically proven cancer No other therapeutic proposal Treatment can be orally taken Radiologic proof of evolutive character of the disease Effective contraception Hypercalcemia ( Ca &gt; 2.65 mmol/l) Breast cancer Thrombosis or pulmonary embolism Dysphagia, malabsorption Polynuclear neutrophil leukocytes &lt; 1000/mm3 Treatment with Tegretol Active and uncontrolled infection Evolutive psychiatric disease Pregnant or lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Cancer, palliative treatment</keyword>
</DOC>